Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus

Clinical and Experimental Immunology

Volumn 175, Issue 3, 2014, Pages 485-497

  Zouk, H ^a,b   D'Hennezel, E ^a   Du, X ^a   Ounissi Benkalha, H ^a   Piccirillo, C A ^a   Polychronakos, C ^a,b,c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Co culture assay; Flow cytometry; Subcellular localization; T cell activation and proliferation

Indexed keywords

C TYPE LECTIN DOMAIN FAMILY 16A; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LECTIN; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIVISION; CELL STRAIN K 562; CELLULAR DISTRIBUTION; CHROMOSOME 16P; COCULTURE; CONTROLLED STUDY; DILUTION; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IMMUNOFLUORESCENCE; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CO-CULTURE ASSAY; FLOW-CYTOMETRY; SUBCELLULAR LOCALIZATION; T CELL ACTIVATION AND PROLIFERATION;

ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CHROMOSOMES, HUMAN, PAIR 16; COCULTURE TECHNIQUES; ENDOPLASMIC RETICULUM; GENE KNOCKDOWN TECHNIQUES; GENETIC LOCI; HUMANS; K562 CELLS; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MONOSACCHARIDE TRANSPORT PROTEINS; PROTEIN TRANSPORT; T-LYMPHOCYTES;

EID: 84893381788     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12240     Document Type: Article

References (44)

1. Hakonarson H, Grant SF, Bradfield JP etal. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448:591-594.
2. Burton PR, Clayton DG, Cardon LR etal. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447:661-678.
3. Hafler DA, Compston A, Sawcer S etal. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357:851-862.
4. Ban M. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009; 10:11-14.
5. Skinningsrud B, Husebye ES, Pearce SH etal. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 2008; 93:3310-3317.
6. Awata T, Kawasaki E, Tanaka S etal. Association of type 1 diabetes with two loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 2009; 94:231-235.
7. Concannon P, Onengut-Gumuscu S, Todd JA etal. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 2008; 57:2858-2861.
8. Todd JA, Walker NM, Cooper JD etal. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39:857-864.
9. Barrett JC, Clayton DG, Concannon P etal. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41:703-707.
10. Wu X, Zhu X, Wang X etal. Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population. Clin Endocrinol (Oxf) 2009; 71:46-49.
11. Martinez A, Perdigones N, Cenit MC etal. Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 2010; 69:309-311.
12. Nejentsev S, Walker N, Riches D etal. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009; 324:387-389.
13. Mero IL, Ban M, Lorentzen AR etal. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes Immun 2011; 12:191-198.
14. Leikfoss IS, Mero IL, Dahle MK etal. Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus. Genes Immun 2012; 14:62-66.
15. Davison LJ, Wallace C, Cooper JD etal. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum Mol Genet 2012; 21:322-333.
16. Sigrist CJ, Cerutti L, de Castro E etal. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res 2010; 38:D161-166.
17. Finn RD, Mistry J, Tate J etal. The Pfam protein families database. Nucleic Acids Res 2010; 38:D211-222.
18. Underhill DM, Goodridge HS. The many faces of ITAMs. Trends Immunol 2007; 28:66-73.
19. Su AI, Cooke MP, Ching KA etal. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002; 99:4465-4470.
20. Wu C, Orozco C, Boyer J etal. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009; 10:R130.
21. Poirot L, Benoist C, Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci USA 2004; 101:8102-8107.
22. Rodacki M, Svoren B, Butty V etal. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007; 56:177-185.
23. Marino E, Grey ST. B cells as effectors and regulators of autoimmunity. Autoimmunity 2012; 45:377-387.
24. Calderon B, Unanue ER. Antigen presentation events in autoimmune diabetes. Curr Opin Immunol 2012; 24:119-128.
25. Kim S, Wairkar YP, Daniels RW etal. The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation. J Cell Biol 2010; 188:717-734.
26. Wu X, Li J, Chen C etal. Involvement of CLEC16A in activation of astrocytes after LPS treated. Neurochem Res 2012; 37:5-14.
27. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-258.
28. International HapMap Consortium. The International HapMap Project. Nature 2003; 426:789-796.
29. Simms PE, Ellis TM. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol 1996; 3:301-304.
30. Mardiney M, 3rd, Brown MR, Fleisher TA. Measurement of T cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry 1996; 26:305-310.
31. Punzon C, Resino S, Bellon JM etal. Analysis of the systemic immune response in HIV-1-infected patients suffering from opportunistic Candida infection. Eur Cytokine Netw 2002; 13:215-223.
32. Ormerod MG. Cell proliferation. In: Ormerod MG, ed. Flow cytometry-a basic introduction. Oxford: Oxford University Press, 2008:80-91.
33. Schurgers E, Kelchtermans H, Mitera T etal. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T cell proliferation and collagen-induced arthritis. Arthritis Res Ther 2010; 12:R31.
34. Schultz N, Marenstein DR, De Angelis DA etal. Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-beta pathway and reveal microRNA regulation of TGFBR2. Silence 2011; 2:3.
35. Mocellin S, Provenzano M. RNA interference: learning gene knock-down from cell physiology. J Transl Med 2004; 2:39.
36. Moretti L, Corpuz S, Giuliodori L, Stramigioli S, Martin PJ. Quantitation of T cell depletion by limiting dilution analysis. Haematologica 1991; 76:188-192.
37. Lanier LL, O'Fallon S, Somoza C etal. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97-105.
38. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40:1-14.
39. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993; 11:403-450.
40. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 1994; 12:259-293.
41. Nilsson T, Warren G. Retention and retrieval in the endoplasmic reticulum and the Golgi apparatus. Curr Opin Cell Biol 1994; 6:517-521.
42. Frank K, Sippl MJ. High-performance signal peptide prediction based on sequence alignment techniques. Bioinformatics 2008; 24:2172-2176.
43. Petersen TN, Brunak S, von Heijne G etal. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011; 8:785-786.
44. Horton P, Park KJ, Obayashi T etal. WoLF PSORT: protein localization predictor. Nucleic Acids Res 2007; 35:W585-587.